Tenax Therapeutics
TENX
19 hedge funds and large institutions have $30.1M invested in Tenax Therapeutics in 2014 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 3 closing their positions.
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
6% more funds holding
Funds holding: 18 → 19 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
22% less capital invested
Capital invested by funds: $38.5M → $30.1M (-$8.33M)
99% less call options, than puts
Call options by funds: $12K | Put options by funds: $1.98M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$8.09M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$898K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$642K |
| 4 |
BCM
Bluefin Capital Management
New York
|
+$385K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$385K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$3.98M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$1.28M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$666K |
| 4 |
DM
Deerfield Management
New York
|
-$446K |
| 5 |
D.E. Shaw & Co
New York
|
-$257K |
TENX Hedge Fund Activity: Q3 2014 in Review
19 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Tenax Therapeutics (TENX) for Q3 2014, worth a combined $30.1M — down 22% from $38.5M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new TENX positions and 3 closed out — a net gain of 1 holder — while 4 added to existing stakes and 3 trimmed.
The largest buyer was RA Capital Management, adding an estimated $8.09M. The largest seller was Great Point Partners, cutting an estimated $3.98M.
- 19 institutional investors held Tenax Therapeutics (TENX) as of Q3 2014, up from 18 in Q2 2014.
- Funds reported $30.1M of Tenax Therapeutics stock for Q3 2014, down 22% quarter-over-quarter.
- 4 funds opened new Tenax Therapeutics positions in Q3 2014 and 3 closed out, a net change of +1 holder.
- The largest Tenax Therapeutics buyer in Q3 2014 was RA Capital Management, an estimated $8.09M added.
- The largest Tenax Therapeutics seller in Q3 2014 was Great Point Partners, an estimated $3.98M sold.
Based on aggregated 13F filings for Q3 2014.